Preeclampsia Diagnostics Market, Test Type (Blood Tests, Urine Analysis, and Others), By Product Type (Instruments and Consumables), By End User (Hospital, Specialty Clinics, Diagnostic Centers, and Others), By Region (North America, Latin America, Europe

Preeclampsia Diagnostics Market, Test Type (Blood Tests, Urine Analysis, and Others), By Product Type (Instruments and Consumables), By End User (Hospital, Specialty Clinics, Diagnostic Centers, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Preeclampsia is formerly known as toxemia. Preeclampsia occurs when women have high blood pressure and possibly protein in urine during pregnancy or after delivery. Preeclampsia may result in damage to the kidneys, liver, lung, heart, or eyes, and may cause a stroke or other brain injury. Preeclampsia can lead to eclampsia, a serious condition that can have health risks for both mother and baby and in rare cases can even cause death. If preeclampsia leads to seizures, then women have eclampsia. Symptoms of preeclampsia include persistent headache, abnormal swelling in hands and face, sudden weight gain, changes in vision, and pain in the right upper abdomen. The only cure for preeclampsia is to give birth. Even after delivery, symptoms of preeclampsia can last 6 weeks or more.
Market Dynamics
Key players in the market are focusing on growth strategies such as agreements, collaborations, and product launches, which are expected to drive the market growth during the forecast period. For instance, in February 2016, Diabetomics, Inc., a privately-held global medical diagnostics company, announced that the company had entered into a licensing and distribution agreement for a clinical test with BD (Becton, Dickinson and Company), a leading global medical technology company to conduct a newly developed pregnancy specific metabolic assay for the early detection of preeclampsia and gestational diabetes. In March 2015, Siemens Healthineers AG launched two new advanced urine testing solutions for the U.S. central laboratories, namely, the CLINITEK Novus Automated Urine Chemistry Analyzer and the CLINITEK AUWi PRO Automated Urine Workstation.
Key features of the study:
This report provides in-depth analysis of the global preeclampsia diagnostics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preeclampsia diagnostics market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Diabetomics, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Siemens Healthineers AG, DRG INSTRUMENTS GMBH, Metabolomic Diagnostics Ltd., Sera Prognostics, MOMM Diagnostics, Miraculins Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preeclampsia diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Preeclampsia Diagnostics Market.
Detailed Segmentation:
Global Preeclampsia Diagnostics Market, By Test Type:
Blood Tests
Urine Analysis
Others
Global Preeclampsia Diagnostics Market, By Product Type:
Instruments
Consumables
Global Preeclampsia Diagnostics Market, By End User:
Hospital
Specialty Clinics
Diagnostic Centers
Others
Global Preeclampsia Diagnostics Market, By Region:
North America
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
By Country
U.S.
Canada
Latin America
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
By Country
GCC
Israel
Rest of Middle East
Africa
Test Type
Blood Tests
Urine Analysis
Others
Product Type
Instruments
Consumables
End User
Hospital
Specialty Clinics
Diagnostic Centers
Others
By Country
South Africa
Central Africa
North Africa
Company Profiles
Diabetomics, Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
PerkinElmer Inc.
Siemens Healthineers AG
DRG INSTRUMENTS GMBH
Metabolomic Diagnostics Ltd.
Sera Prognostics
MOMM Diagnostics
Miraculins Inc.
“*” marked represents similar segmentation in other categories in the respective section